CD137 is primarily expressed on the surface of activated T cells, and our study found that CD137 was predominantly expressed on the surface of CD8+ T cells in the GC immune microenvironment and may positively correlate with tumor differentiation. Here, TNFRSF9 is linked to neoplasm.